Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non-Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial (vol 41, pg 3877, 2023)
Roy S. Herbst,Yi-Long Wu,Thomas John,Christian Grohe,Margarita Majem,Jie Wang,Terufumi Kato,Jonathan W. Goldman,Konstantin Laktionov,Sang-We Kim,Chong-Jen Yu,Huu Vinh Vu, Shun Lu,Kye Young Lee,Guzel Mukhametshina,Charuwan Akewanlop,Filippo de Marinis,Laura Bonanno,Manuel Domine,Frances A. Shepherd,Damien Urban,Xiangning Huang,Ana Bolanos,Marta Stachowiak,Masahiro Tsuboi JOURNAL OF CLINICAL ONCOLOGY（2023）
AI 理解论文
溯源树
样例
